Drugs / PYEX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06608459 | Dec 2024 → Dec 2026 expected | substance-related disorder | Filament Health Corp. | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PYEX | “The investigational medicinal product PEX010 is a capsule for oral administration that contains the drug substance PYEX.” NCT06608459 ↗ |